Yun et al. identified FDX1-rs10488764 as a lung cancer risk polymorphism among smokers and non-smokers as well as three different pathological subgroups, which provided new clues to the role of FDX1 in disease development (Yun et al., 2022). This evidence concerns the gene FDX1 and lung cancer.